2022 - Research.com Best Scientist Award
2020 - Fellow of the American Association for the Advancement of Science (AAAS)
2018 - Member of the National Academy of Medicine (NAM)
2009 - Paul Marks Prize for Cancer Research, Memorial Sloan Kettering Cancer Center
Member of the Association of American Physicians
Matthew Meyerson mostly deals with Cancer research, Genetics, Cancer, Mutation and Gene. His Cancer research research is multidisciplinary, relying on both DNA methylation, Epidermal growth factor receptor, Immunology, microRNA and Lung cancer. Genome, Carcinogenesis, Human genome, Exome and Germline mutation are the primary areas of interest in his Genetics study.
His Cancer research incorporates elements of Exome sequencing, Gene expression profiling, Somatic cell, Gene dosage and Human genetics. His Gene expression profiling research is multidisciplinary, incorporating elements of Mesenchymal Glioblastoma, Computational biology and Bioinformatics. His Mutation research includes elements of Genome-wide association study, Melanoma, Neuroblastoma and Kinase.
Matthew Meyerson focuses on Cancer research, Genetics, Cancer, Gene and Mutation. His biological study spans a wide range of topics, including Epidermal growth factor receptor, Carcinogenesis, KRAS, Lung cancer and Adenocarcinoma. His Epidermal growth factor receptor research integrates issues from Tyrosine kinase and Molecular biology.
His research in Adenocarcinoma intersects with topics in Lung and Gene expression profiling. Genetics is represented through his Genome, Human genome, Exome, Exome sequencing and Germline mutation research. His studies deal with areas such as Oncology, Bioinformatics and Pathology as well as Cancer.
His scientific interests lie mostly in Cancer research, Cancer, Gene, Genetics and Computational biology. His work carried out in the field of Cancer research brings together such families of science as Oncogene, Mutant, KRAS, Colorectal cancer and Adenocarcinoma. The Colorectal cancer study combines topics in areas such as Carcinogenesis, Fusobacterium and Microsatellite instability.
He combines subjects such as SOS1, Lung and Gene expression profiling with his study of Adenocarcinoma. His Cancer study incorporates themes from Cell, Kinase and Oncology. His work deals with themes such as Genome, Human genome and Sequence analysis, which intersect with Computational biology.
His primary scientific interests are in Cancer research, Cancer, Gene, Genetics and Mutation. His Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Colorectal cancer, microRNA and DNA methylation. The concepts of his Cancer study are interwoven with issues in Missense mutation and Oncology.
Genetics is often connected to Drug response in his work. His studies in Mutation integrate themes in fields like Bladder cancer, Molecular biology, Breast cancer and Promoter. The various areas that Matthew Meyerson examines in his Adenocarcinoma study include Lung cancer and Lung.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
J. Guillermo Paez;Pasi A. Jänne;Pasi A. Jänne;Jeffrey C. Lee;Sean Tracy.
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak;Katherine A. Hoadley;Elizabeth Purdom;Victoria Wang.
Cancer Cell (2010)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt.
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina;Giordano Caponigro;Nicolas Stransky;Kavitha Venkatesan.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir.
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny;Matthew N. Bainbridge;Kyle Chang;Huyen H. Dinh.
Integrated genomic analyses of ovarian carcinoma
D. Bell;A. Berchuck;M. Birrer;J. Chien.
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Susumu Kobayashi;Titus J. Boggon;Tajhal Dayaram;Pasi A. Jänne.
The New England Journal of Medicine (2005)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass;Vesteinn Thorsson;Ilya Shmulevich;Sheila M. Reynolds.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: